KRAS and cancer: Evidence suggests that GC1 plays a key role in mutant KRAS-driven metabolic reprogramming of cancer cells through multiple mechanisms, including enhanced glutaminolysis, maintenance of redox homeostasis, and epigenetic regulation of genes involved in cell growth, proliferation, and stemness.